In the present study, we investigated placental and maternal blood sFlt1/PlGF expressions in GDM and GDM-PE pregnancies cases in order to explore a possible differential regulation of angiogenic molecules compared to CTRL and PE patients. The gene discussed is PGF; the disease is gestational diabetes.